Immunic Inc (NASDAQ: IMUX) on Monday, plunged -3.36% from the previous trading day, before settling in for the closing price of $0.96. Within the past 52 weeks, IMUX’s price has moved between $0.56 and $2.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 26.01%. The company achieved an average annual earnings per share of 30.99%. With a float of $92.55 million, this company’s outstanding shares have now reached $95.82 million.
The extent of productivity of a business whose workforce counts for 91 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Immunic Inc (IMUX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Immunic Inc is 3.42%, while institutional ownership is 40.52%. The most recent insider transaction that took place on Jun 13 ’25, was worth 16,694. In this transaction Executive Chairman of this company bought 20,000 shares at a rate of $0.83, taking the stock ownership to the 36,032 shares. Before that another transaction happened on Jun 05 ’25, when Company’s President and COO bought 12,512 for $0.79, making the entire transaction worth $9,884. This insider now owns 12,512 shares in total.
Immunic Inc (IMUX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 30.99% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.24% during the next five years compared to 26.01% growth over the previous five years of trading.
Immunic Inc (NASDAQ: IMUX) Trading Performance Indicators
Immunic Inc (IMUX) is currently performing well based on its current performance indicators. A quick ratio of 0.74 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.98, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Immunic Inc (IMUX)
The latest stats from [Immunic Inc, IMUX] show that its last 5-days average volume of 1.41 million was superior to 1.26 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 74.76%.
During the past 100 days, Immunic Inc’s (IMUX) raw stochastic average was set at 47.04%, which indicates a significant decrease from 70.06% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0592 in the past 14 days, which was lower than the 0.0785 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8337, while its 200-day Moving Average is $1.0695.
